Article
http://www.researchprotection.org/sharavTestimonyArmyMedDept020507.htm has moved to:
https://ahrp.org/testimonypresentations/armymeddept.php
Please click on the link above to visit this page, and adjust your bookmarks accordingly.
Similar Posts
What’s a Patient to Think? Prescription for Confusion – NY Times Editorial
What’s a Patient to Think? Prescription for Confusion – NY Times Editorial Tue, 28 Dec 2004 At long last, The New York Times has validated the well-placed anger and frustration that patients feel at having their trust in medicine and the nation’s oversight agents betrayed: “Now I just don’t trust…
OHRP Compliance Letters
ETHICAL AND POLICY ISSUES IN RESEARCH INVOLVING HUMAN PARTICIPANTS National Bioethics Advisory Commitee (NBAC) Final Report, 2001 Exhibit 3.1: Office of Protection from Research Risks (OPRR) Compliance Oversight Investigations Resulting in Restrictions/Actions to Institutions that have Multiple Project Assurances (MPA) between January 1990 – June 2000 Year, Institution and Action…
High Mortality Rates in Clinical Trials
High Mortality Rates in Clinical Trials Mon, 4 Nov 2002 Serious concerns are being raised about the high death rate in clinical trials. According to several articles in the American Journal of Respiratory and Critical Care Medicine, the lives of critically ill patients have been put at increased risk due…
P&G Osteoperosis Drug Trials Spark Major Academic Research Debate Re: Concealed Data
P&G Osteoperosis Drug Trials Spark Major Academic Research Debate Re: Concealed Data Friday, November 25, 2005 Dr. Aubrey Blumsohn: “No self-respecting scientist could ever be expected to publish findings based on data to which they do not have complete and full access.” Sri David Weatherall, Professor Emeritus, Oxford: “People need…
Nass – Senate Subcommittee on Bioterrorism & Public Health Preparedness – Biodefense
Submitted Testimony of Meryl Nass, MD Mount Desert Island Hospital Bar Harbor, Maine 04609 (207) 288-5082 ext. 220 Senate Subcommittee on Bioterrorism and Public Health Preparedness Hearing: Biodefense: Next Steps Tuesday, February 8, 2005, 10 am SD-430 Dirksen Senate Office Building Thank you for the opportunity to submit this testimony…
Columbia Journalism Review–The Complicity of the Media in Drug Marketing
Columbia Journalism Review–The Complicity of the Media in Drug Marketing Wed, 27 Jul 2005 An excellent article in the Columbia Journalism Review examines pharmaceutical industry hype and the media’s role in helping that industry create false impressions about the safety and benefits of newly marketed drugs: “stories trumpeting new drugs…